What is in the Mod GRF 1-29 & Ipamorelin blend?
This vial combines two research peptides that act on different receptors involved in growth hormone release, with 10mg of peptide in total.
- Mod GRF 1-29 (CJC-1295 without DAC): GHRH(1-29) with four amino-acid substitutions, which acts on the GHRH receptor.
- Ipamorelin: a synthetic pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) that acts selectively on the ghrelin (GHS) receptor.
Mod GRF 1-29 & Ipamorelin vs CJC-1295 & Ipamorelin
This blend always contains CJC-1295 without DAC (Mod GRF 1-29), which has no albumin-binding linker and is cleared within minutes to hours. Our CJC-1295 & Ipamorelin Blend is listed under the general name “CJC-1295”, which can also mean the longer-acting form with DAC (a drug affinity complex that binds albumin and extends half-life to several days). The ipamorelin part and the 10mg total are the same. Ask us which form a batch contains if you are comparing the two.
Regulatory status
Neither peptide is an approved medicine. GHRH analogues and growth hormone secretagogues are prohibited at all times in competitive sport by the World Anti-Doping Agency. This product is sold for laboratory research use only.
Related products
- Each peptide on its own: Mod GRF 1-29 and Ipamorelin.
- Other ipamorelin combinations: CJC-1295 & Ipamorelin, Sermorelin & Ipamorelin and Tesamorelin & Ipamorelin.
Handling and research-use notice
Store and handle this material as stated on the label and certificate of analysis for your batch; see our guide to storing research peptides. This product is sold for laboratory research use only. It is not a medicine or supplement and is not for human or veterinary use.
